Alberto Arranz

1.0k total citations
16 papers, 504 citations indexed

About

Alberto Arranz is a scholar working on Infectious Diseases, Virology and Neurology. According to data from OpenAlex, Alberto Arranz has authored 16 papers receiving a total of 504 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 5 papers in Virology and 3 papers in Neurology. Recurrent topics in Alberto Arranz's work include HIV/AIDS drug development and treatment (9 papers), HIV/AIDS Research and Interventions (7 papers) and HIV Research and Treatment (5 papers). Alberto Arranz is often cited by papers focused on HIV/AIDS drug development and treatment (9 papers), HIV/AIDS Research and Interventions (7 papers) and HIV Research and Treatment (5 papers). Alberto Arranz collaborates with scholars based in Spain. Alberto Arranz's co-authors include José Ramón Arribas, Rafaël Delgado, Federico Pulido, Juan González‐García, Juan Pasquau, Maria Jesús Pérez‐Elías, Joaquín Portilla, Rafael Rubio, José Antonio Iribarren and Pilar Miralles and has published in prestigious journals such as Clinical Infectious Diseases, International Journal of Molecular Sciences and AIDS.

In The Last Decade

Alberto Arranz

14 papers receiving 479 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alberto Arranz Spain 10 473 334 146 47 17 16 504
Jhon Rojas Spain 11 296 0.6× 141 0.4× 86 0.6× 77 1.6× 18 1.1× 19 355
Arturo Ciccullo Italy 13 430 0.9× 307 0.9× 148 1.0× 126 2.7× 21 1.2× 70 510
Nicola Mackie United Kingdom 13 369 0.8× 275 0.8× 99 0.7× 98 2.1× 19 1.1× 31 448
Eugénio Teófilo Portugal 9 254 0.5× 178 0.5× 63 0.4× 74 1.6× 13 0.8× 22 319
Fabienne Caby France 9 232 0.5× 231 0.7× 123 0.8× 92 2.0× 24 1.4× 26 365
Ashwaq Hermes United States 7 277 0.6× 174 0.5× 80 0.5× 58 1.2× 19 1.1× 8 359
Giampaolo Quinzan Italy 9 372 0.8× 242 0.7× 124 0.8× 91 1.9× 6 0.4× 15 433
Yvon van Delft Netherlands 12 440 0.9× 354 1.1× 132 0.9× 79 1.7× 12 0.7× 28 481
Robin L. Fisher United States 7 332 0.7× 254 0.8× 269 1.8× 59 1.3× 25 1.5× 8 440
Elisabetta Chiesa Italy 11 306 0.6× 242 0.7× 96 0.7× 63 1.3× 11 0.6× 17 351

Countries citing papers authored by Alberto Arranz

Since Specialization
Citations

This map shows the geographic impact of Alberto Arranz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alberto Arranz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alberto Arranz more than expected).

Fields of papers citing papers by Alberto Arranz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alberto Arranz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alberto Arranz. The network helps show where Alberto Arranz may publish in the future.

Co-authorship network of co-authors of Alberto Arranz

This figure shows the co-authorship network connecting the top 25 collaborators of Alberto Arranz. A scholar is included among the top collaborators of Alberto Arranz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alberto Arranz. Alberto Arranz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Valencia, Eulalia, Marta Montero, José Sanz, et al.. (2024). Prospective study for the early detection of lung carcinoma in patients with HIV infection (GESIDA study 8815). Enfermedades infecciosas y microbiologia clinica (English ed ). 43(3). 125–132.
2.
Valencia, Eulalia, Marta Montero, José Sanz, et al.. (2024). Estudio prospectivo para la detección precoz de carcinoma pulmonar en pacientes con infección por VIH (estudio GESIDA 8815). Enfermedades Infecciosas y Microbiología Clínica. 43(3). 125–132.
3.
Monserrat, Jorge, Ana M. Gómez-Lahoz, Miguel Á. Ortega, et al.. (2022). Role of Innate and Adaptive Cytokines in the Survival of COVID-19 Patients. International Journal of Molecular Sciences. 23(18). 10344–10344. 20 indexed citations
4.
Monserrat, Jorge, Ángel Asúnsolo, Ana M. Gómez-Lahoz, et al.. (2021). Impact of the Innate Inflammatory Response on ICU Admission and Death in Hospitalized Patients with COVID-19. Biomedicines. 9(11). 1675–1675. 6 indexed citations
5.
Álvarez‐Mon, Melchor, Miguel Á. Ortega, Jorge Monserrat, et al.. (2021). A Predictive Model and Risk Factors for Case Fatality of COVID-19. Journal of Personalized Medicine. 11(1). 36–36. 18 indexed citations
6.
Pedrol, Enric, et al.. (2014). Causas que justifican el cambio del tratamiento antirretroviral en personas con infección por el VIH en España (años 2010-2011). Estudio SWITCH AUDIT. Revista española de quimioterapia. Suplemento. 27(2). 93–97. 5 indexed citations
7.
Pedrol, Enric, et al.. (2014). [Reasons for antiretroviral treatment change in HIV+ patients in Spain in 2010-2011. SWITCH AUDIT Study].. PubMed. 27(2). 93–7. 4 indexed citations
8.
Arribas, José Ramón, Rafaël Delgado, Alberto Arranz, et al.. (2009). Lopinavir-Ritonavir Monotherapy Versus Lopinavir-Ritonavir and 2 Nucleosides for Maintenance Therapy of HIV: 96-Week Analysis. JAIDS Journal of Acquired Immune Deficiency Syndromes. 51(2). 147–152. 87 indexed citations
9.
Pulido, Federico, Ignacio Valero, Rafaël Delgado, et al.. (2009). Risk factors for loss of virological suppression in patients receiving lopinavir/ritonavir monotherapy for maintenance of HIV suppression. Antiviral Therapy. 14(2). 195–201. 50 indexed citations
10.
Pulido, Federico, Rafaël Delgado, Ignacio Valero, et al.. (2008). Long-term (4 years) efficacy of lopinavir/ritonavir monotherapy for maintenance of HIV suppression. Journal of Antimicrobial Chemotherapy. 61(6). 1359–1361. 37 indexed citations
11.
Velasco, María, Miguel Cervero, José Sanz, et al.. (2008). The changing pattern of tuberculosis and HIV co‐infection in immigrants and Spaniards in the last 20 years. HIV Medicine. 9(4). 227–233. 11 indexed citations
12.
Pulido, Federico, José Ramón Arribas, Rafaël Delgado, et al.. (2008). Lopinavir-ritonavir monotherapy versus lopinavir-ritonavir and two nucleosides for maintenance therapy of HIV. AIDS. 22(2). F1–F9. 120 indexed citations
13.
Arribas, José Ramón, Federico Pulido, Rafaël Delgado, et al.. (2005). Lopinavir/Ritonavir as Single-Drug Therapy for Maintenance of HIV-1 Viral Suppression. JAIDS Journal of Acquired Immune Deficiency Syndromes. 40(3). 280–287. 112 indexed citations
14.
Gil, Paloma, Miguel Górgolas, Vicente Estrada, et al.. (2004). Long‐Term Efficacy and Safety of Protease Inhibitor Switching to Nevirapine in HIV‐Infected Patients with Undetectable Virus Load. Clinical Infectious Diseases. 39(7). 1024–1029. 18 indexed citations
15.
Knobel, Hernando, José M. Miró, Beatriz Mahíllo, et al.. (2004). Failure of Cetirizine to Prevent Nevirapine-Associated Rash. JAIDS Journal of Acquired Immune Deficiency Syndromes. 37(2). 1276–1281. 14 indexed citations
16.
Arranz, Alberto, et al.. (2003). Calidad y mejora continua. Dialnet (Universidad de la Rioja). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jhon Rojas Breakdown of academic impact, for papers by Arturo Ciccullo Breakdown of academic impact, for papers by Nicola Mackie Breakdown of academic impact, for papers by Eugénio Teófilo Breakdown of academic impact, for papers by Fabienne Caby Breakdown of academic impact, for papers by Ashwaq Hermes Breakdown of academic impact, for papers by Giampaolo Quinzan Breakdown of academic impact, for papers by Yvon van Delft Breakdown of academic impact, for papers by Robin L. Fisher Breakdown of academic impact, for papers by Elisabetta Chiesa
Rankless by CCL
2026